NICOLE CAMPBELL: Open Payments
NPI 1104545433 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 34 payments from 24 companies in 2025. Trend: 2023 $368 · 2024 $788 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $71 |
| ABBVIE INC. | 4 | $69 |
| Alexion Pharmaceuticals, Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $46 |
| Lundbeck LLC | 2 | $44 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $27 |
Products named: Fintepla, QULIPTA, ULTOMIRIS, Ozempic, VYEPTI, JARDIANCE, ELIQUIS, REPATHA.
Industry payments across NY — which companies pay providers there.
